---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036161"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:53:59.296031+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma issues $250K promissory note to Coventry; $25K OID, convertible on default

## Summary
- Principal amount $250K; original issue discount $25K, net proceeds $200K.
- 10% annual interest; ten monthly payments of $27,500 starting Nov 4, 2024, due Sept 4, 2025.
- Upon event of default, note converts to common stock at 90% of lowest 20-day trading price before conversion.
- Company issued 500K commitment shares; 350K to be returned to treasury if no default occurs.
- $152K of proceeds used to repay existing principal and interest to Coventry from a prior note.

## SEC filing metadata
- accession: 0001493152-24-036161
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000149315224036161/0001493152-24-036161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000149315224036161/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036161
- JSON: https://secwatch.observer/filing/0001493152-24-036161.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036161.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.